Reata Pharmaceuticals (RETA) Reports Q2 Loss of $0.05/Share

August 11, 2016 5:04 PM EDT
Get Alerts RETA Hot Sheet
Price: $24.70 -2.22%

Today's EPS Names:
TRN, TXN, SU, More
Trade RETA Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Reata Pharmaceuticals (NASDAQ: RETA) reported Q2 EPS of ($0.05), versus ($0.11) reported last year. Revenue for the quarter came in at $12.4 million, versus $12.4 million reported last year.

For earnings history and earnings-related data on Reata Pharmaceuticals (RETA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment